Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 35327 composition records across product categories including Personal care, Cleaning products and household care, Construction and building materials.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of GLYCERIN in our catalog (epa_cpdat).
Products
35,327
Brands
6
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside GLYCERIN in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 35327 composition records across product categories including Personal care, Cleaning products and household care, Construction and building materials. EPA CPDat classifies this chemical for functional uses including Solvent, Emulsifier, Humectant.
US
FDA
Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 63.64 %w/v
US
FDA
Crema Manos
S'nonas
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 25 mg
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.05 %w/w
US
FDA
Route: BUCCAL; Dosage form: FILM, EXTENDED RELEASE; Maximum daily exposure: 34 mg
US
FDA
Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 230 mg
US
FDA
Route: BUCCAL; Dosage form: MOUTHWASH; Potency: 100 mg/1ml
US
FDA
Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 18 %w/w
US
FDA
Route: DENTAL; Dosage form: SOLUTION; Potency: 15 %w/v
US
FDA
Route: INTRADERMAL; Dosage form: INJECTION; Potency: 1.6 %w/v
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 450 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Potency: 15 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: EMULSION; Potency: 2.2 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 550 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 24100 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 225 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 15 %w/v
US
FDA
Route: IONTOPHORESIS; Dosage form: SYSTEM; Potency: 168.1 mg
US
FDA
Route: NASAL; Dosage form: SOLUTION; Potency: 25 mg/1ml
US
FDA
Route: NASAL; Dosage form: SPRAY; Potency: 22.3 mg/1ml
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 13 mg
US
FDA
Route: OPHTHALMIC; Dosage form: EMULSION; Maximum daily exposure: 3 mg
US
FDA
Route: OPHTHALMIC; Dosage form: GEL; Potency: 0.88 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 6 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 12 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 58 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 2.5 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 3487 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Potency: 14.21 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 265 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 185 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 1800 mg
US
FDA
Route: ORAL; Dosage form: LIQUID; Maximum daily exposure: 2400 mg
US
FDA
Route: ORAL; Dosage form: PASTE; Maximum daily exposure: 3822 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 32400 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION, CONCENTRATE; Potency: 200 mg/1ml
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 26208 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 2000 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 750 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 16734 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 42 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 12 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 1 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 7 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 1.55 mg
US
FDA
Route: PERIODONTAL; Dosage form: TABLET; Potency: 0.53 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Maximum daily exposure: 440 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: 5 %w/w
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 450 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 15 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: 1.6 %w/v
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Maximum daily exposure: 42 mg
US
FDA
Route: TOPICAL; Dosage form: CLOTH; Potency: 0.05 mg/mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 1720 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Maximum daily exposure: 55 mg
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 500 mg
US
FDA
Route: TOPICAL; Dosage form: LIQUID; Potency: 2.5 %w/w
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 3990 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 1971 mg
US
FDA
Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 18144 mg
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: 306.2 mg
US
FDA
Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 500 mg
US
FDA
Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 60 mg
US
FDA
Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: 227.9 mg
US
FDA
FDA NDC lists this ingredient in 316 active drug products and 339 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.